Ribociclib in combination with endocrine therapy and goserelin for previously untreated hormone receptor-positive, HER2-negative advanced breast cancer in premenopausal women (ID1307)
In development
Reference number: GID-TA10261
Expected publication date: TBC
Documents
Documents created during the development process.
Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators